Last reviewed · How we verify
CU-40102 Spray
CU-40102 is a topical spray formulation designed to treat skin conditions, likely through local delivery of an active pharmaceutical ingredient to affected areas.
CU-40102 is a topical spray formulation designed to treat skin conditions, likely through local delivery of an active pharmaceutical ingredient to affected areas. Used for Dermatological condition (specific indication not publicly disclosed).
At a glance
| Generic name | CU-40102 Spray |
|---|---|
| Sponsor | Cutia Therapeutics（Wuxi）Co.,Ltd |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
As a spray formulation, CU-40102 delivers medication directly to the skin surface, allowing for localized therapeutic action while minimizing systemic exposure. The specific mechanism depends on the active ingredient, which is not publicly disclosed in available sources. The spray format enables convenient application and potentially improved patient compliance for dermatological treatment.
Approved indications
- Dermatological condition (specific indication not publicly disclosed)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CU-40102 Spray CI brief — competitive landscape report
- CU-40102 Spray updates RSS · CI watch RSS
- Cutia Therapeutics（Wuxi）Co.,Ltd portfolio CI